✦ LIBER ✦

Clinical experience of weekly paclitaxel-based treatment as preoperative chemotherapy for patients with primary breast cancer

✍ Scribed by Masahiro Watatani; Kazuki Ueda; Koji Daito; Tatsuya Azumi; Teruhiko Hirai; Munehisa Yamato; Toshiya Hojo; Kyoko Hirai; Hiroki Inui; Hitoshi Shiozaki

Publisher: Springer Japan
Year: 2004
Tongue: English
Weight: 602 KB
Volume: 11
Category: Article
ISSN: 1340-6868
DOI: 10.1007/bf02968300

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Evaluation of the worth of Corynebacteri

Evaluation of the worth of Corynebacterium parvum in conjunction with chemotherapy as adjuvant treatment for primary breast cancer: Eight-year results from the national surgical adjuvant breast and bowel project B-10

✍ Bernard Fisher; Ann Brown; Norman Wolmark; Edwin R. Fisher; Carol Redmond; D. La 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 854 KB

During the 1970s, information obtained from animal tumor models and from patients with a spectrum of solid tumors indicated the worth of a variety of immunostimulating agents. These findings provided a biological and clinical rationale for conducting randomized trials to evaluate the worth of those

Phase 2 trial of primary systemic therap

Phase 2 trial of primary systemic therapy with doxorubicin and docetaxel followed by surgery, radiotherapy, and adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil based on clinical and pathologic response in patients with stage IIB to III breast cancer : Long-term results from The University of Texas M. D. Anderson Cancer Center Study ID97-099

✍ Ricardo H. Alvarez; Daniel J. Booser; Massimo Cristofanilli; Aysegul A. Sahin; E 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 199 KB 👁 2 views